Journal article icon

Journal article

The effect of moderate weight loss on a non-invasive biomarker of liver fibrosis: a randomised controlled trial

Abstract:

Background: Referral to weight loss programmes is the only effective treatment for non-alcoholic fatty liver disease (NAFLD). Clinicians should advise weight loss and screen for liver fibrosis using the Enhanced Liver Fibrosis (ELF) score.

Aim:To examine if the ELF score changes with weight loss.

Design and Setting: Randomised controlled trial (ISRCTN85485463) in UK primary care during 2007–2008.

Method:

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1159/000505667

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-1955-7234
More by this author
Institution:
University of Oxford
Department:
Primary Care Health Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Primary Care Health Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Primary Care Health Sciences
Role:
Author
More from this funder
Name:
Oxford Biomedical Research Centre
Grant:
A93300
Publisher:
Karger Publishers Open Access
Journal:
Obesity Facts More from this journal
Volume:
13
Issue:
2
Pages:
144–151
Publication date:
2020-03-20
Acceptance date:
2019-12-20
DOI:
EISSN:
1662-4033
ISSN:
1662-4025
Language:
English
Keywords:
Pubs id:
pubs:1078505
UUID:
uuid:0d3c0ddd-f3a7-47ba-8333-83300f6db99b
Local pid:
pubs:1078505
Source identifiers:
1078505
Deposit date:
2019-12-20

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP